Plyometric and Stability Exercise Protocol in Female Basketball Players

May 15, 2024 updated by: Rubén Cuesta-Barriuso, PhD, Universidad Católica San Antonio de Murcia

Efficacy of a Plyometric and Stability Exercise Protocol in Female Basketball Players. A Controlled Clinical Study.

Introduction. Basketball is a high intensity intermittent sport, requiring jumping, running, accelerations and decelerations with changes of direction and lateral movements. Plyometric exercises are a training technique that consists of a cycle of muscle stretching and shortening in which the energy stored in the eccentric phase (lengthening) is released facilitating the production of maximum power in the concentric phase (shortening).

Objective. To analyse the efficacy of a physiotherapy intervention through a protocol of plyometric and stability exercises in the improvement of vertical jump, stability, flexibility and agility in federated female basketball players. The primary variable will be the vertical jump (My jump 2.0). Secondary variables will be stability (Y balance test), flexibility (Sit and Reach) and agility (T-Test).

Methods. Controlled, single-blind clinical study. 20 athletes will be randomised to the experimental and control groups. The intervention of the experimental group will consist of a protocol using plyometric and stability exercises. The athletes included in the control group will not perform any intervention and will continue with their usual routine. The intervention period will last 6 weeks, with a periodicity of 2 weekly sessions of 20 minutes each.

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Murcia, Spain, 30107
        • Universidad Católica San Antonio, Murcia

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Female players over 18 years of age.
  • That during the study period they play basketball competing in the 1st Women's Division 1 category of the Basketball Federation of the Region of Murcia.
  • That they perform strength exercises at least once a week.
  • That they sign the informed consent document.

Exclusion Criteria:

  • Players with knee or ankle injuries in the 6 months prior to the study.
  • Players who use ankle or knee braces regularly.
  • Players with lower limb surgery in the last year.
  • Players whose participation is contraindicated by the team doctor, physiotherapist or physical trainer.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group

The intervention period will last 6 weeks, with a periodicity of 2 weekly sessions of 20 minutes each. All interventions will take place at the Palacio de los Deportes de Murcia. All interventions will be carried out by the same physiotherapist, following the same protocol.

The intervention of the experimental group will consist of a protocol using plyometric and stability exercises.

The intervention period will last 6 weeks, with a periodicity of 2 weekly sessions of 20 minutes each. All interventions will take place at the Palacio de los Deportes de Murcia. All interventions will be carried out by the same physiotherapist, following the same protocol. The intervention of the experimental group will consist of a protocol using plyometric and stability exercises.
No Intervention: Control group
The athletes included in the control group will not undergo any intervention and will continue with their usual routine.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess the changes in vertical jump
Time Frame: Screening visit, within the first seven days after treatment and after six weeks follow-up
The vertical jump will be measured with the My jump 2.0® application. The athlete will be asked to jump as high as possible from a standing position, raising the body in the air by means of an impulse generated by the leg muscles. The evaluation consists of the recording of the jump, the calculation of the height of the vertical jump and the athlete's strength and speed levels. The unit of measurement of this tool is the centimetre, where the greater the distance, the higher the vertical jump.
Screening visit, within the first seven days after treatment and after six weeks follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assess the changes in stability
Time Frame: Screening visit, within the first seven days after treatment and after six weeks follow-up
Stability is measured using the Y balance test. Three strips of adhesive tape are placed on the floor in a Y shape. The athlete, placed in the centre of the Y, will maintain unipodal balance while with the contralateral leg trying to reach the farthest point in each direction (anterior, posteromedial and posterolateral), without lifting the heel of the supporting foot which is the one being evaluated. Three attempts shall be made with each leg. The distance is measured with a tape measure, in centimetres (19), where the greater the distance, the greater the stability.
Screening visit, within the first seven days after treatment and after six weeks follow-up
Assess the changes in flexibility
Time Frame: Screening visit, within the first seven days after treatment and after six weeks follow-up
Flexibility will be assessed with the Sit and Reach test. The athlete will sit on the floor, with her knees straight and her feet placed against the edge of a box. From this position, the participant shall progressively perform a trunk flexion, trying to reach as far as possible with the tips of her hands on the scale graduated in centimetres on the box. The unit of measurement for this test is the centimetre, where the greater the distance reached, the greater the flexibility.
Screening visit, within the first seven days after treatment and after six weeks follow-up
Assess the changes in agility
Time Frame: Screening visit, within the first seven days after treatment and after six weeks follow-up
Agility will be assessed with the T-Test. Four cones should be placed in a T-shape: A at the starting point; B at 9.14 m forward; and C and D at the sides of this at 4.57 m the other two cones. The athlete must go as fast as possible to cone B and touch it with the tip with her right hand, then she must go to the sides touching cones C and D with the hand of the same side, return to touch cone B with the left hand and lastly, move backwards and go over cone A. The unit of measurement is the second, where lower times indicate efficient agility.
Screening visit, within the first seven days after treatment and after six weeks follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 19, 2024

Primary Completion (Estimated)

June 15, 2024

Study Completion (Estimated)

July 1, 2024

Study Registration Dates

First Submitted

May 15, 2024

First Submitted That Met QC Criteria

May 15, 2024

First Posted (Actual)

May 21, 2024

Study Record Updates

Last Update Posted (Actual)

May 21, 2024

Last Update Submitted That Met QC Criteria

May 15, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • PlyoBask

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sports Physical Therapy

Clinical Trials on Intervention

3
Subscribe